Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Pommier

Showing results (41-50 of 625) with videos related to

Pageof 63
Sort By:
Cell Cycle (Georgetown, Tex.)|November 8, 2007
The mammalian DNA replication elongation checkpoint: implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analysesChiara Conti, Jennifer A Seiler, Yves Pommier
Trends in Cancer|June 13, 2017
DNA-Targeted Precision Medicine; Have we Been Caught Sleeping?William C Reinhold, Anish Thomas, Yves Pommier
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1 integrase inhibitors: update and perspectivesElena A Semenova, Christophe Marchand, Yves Pommier
Current Topics in Medicinal Chemistry|June 15, 2004
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trialAllison A Johnson, Christophe Marchand, Yves Pommier
Molecular Biology of the Cell|July 18, 2008
Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complexJosée Guirouilh-Barbat, Christophe Redon, Yves Pommier
Biochimie|December 13, 2006
Mitochondrial topoisomerases and alternative splicing of the human TOP1mt geneHongliang Zhang, Ling-Hua Meng, Yves Pommier
Cell Cycle (Georgetown, Tex.)|August 25, 2004
Apoptotic topoisomerase I-DNA complexes induced by oxygen radicals and mitochondrial dysfunctionOlivier Sordet, Qasim A Khan, Yves Pommier
Anti-Cancer Drugs|August 13, 2002
Ecteinascidin 743: a novel anticancer drug with a unique mechanism of actionGregory J Aune, Takahisa Furuta, Yves Pommier
Oncotarget|January 17, 2019
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecinsYves Pommier, Mark Cushman, James H Doroshow
Frontiers in Molecular Biosciences|April 25, 2022
SUMO: A Swiss Army Knife for Eukaryotic TopoisomerasesYilun Sun, John L Nitiss, Yves Pommier
Pageof 63

Showing results (41-50 of 625) with videos related to

Sort By:
Pageof 63
Cell Cycle (Georgetown, Tex.)|November 8, 2007
The mammalian DNA replication elongation checkpoint: implication of Chk1 and relationship with origin firing as determined by single DNA molecule and single cell analysesChiara Conti, Jennifer A Seiler, Yves Pommier
Trends in Cancer|June 13, 2017
DNA-Targeted Precision Medicine; Have we Been Caught Sleeping?William C Reinhold, Anish Thomas, Yves Pommier
Advances in Pharmacology (San Diego, Calif.)|December 19, 2007
HIV-1 integrase inhibitors: update and perspectivesElena A Semenova, Christophe Marchand, Yves Pommier
Current Topics in Medicinal Chemistry|June 15, 2004
HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trialAllison A Johnson, Christophe Marchand, Yves Pommier
Molecular Biology of the Cell|July 18, 2008
Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complexJosée Guirouilh-Barbat, Christophe Redon, Yves Pommier
Biochimie|December 13, 2006
Mitochondrial topoisomerases and alternative splicing of the human TOP1mt geneHongliang Zhang, Ling-Hua Meng, Yves Pommier
Cell Cycle (Georgetown, Tex.)|August 25, 2004
Apoptotic topoisomerase I-DNA complexes induced by oxygen radicals and mitochondrial dysfunctionOlivier Sordet, Qasim A Khan, Yves Pommier
Anti-Cancer Drugs|August 13, 2002
Ecteinascidin 743: a novel anticancer drug with a unique mechanism of actionGregory J Aune, Takahisa Furuta, Yves Pommier
Oncotarget|January 17, 2019
Novel clinical indenoisoquinoline topoisomerase I inhibitors: a twist around the camptothecinsYves Pommier, Mark Cushman, James H Doroshow
Frontiers in Molecular Biosciences|April 25, 2022
SUMO: A Swiss Army Knife for Eukaryotic TopoisomerasesYilun Sun, John L Nitiss, Yves Pommier
Pageof 63